Mitomics Turns to Optimized Capital Markets for Crowdfunding Round

June 13, 2014 @ 6:35 pm By Samantha Hurst |

Mitomics Seeks $5 Million in Equity Crowdfunding on Optimize Capital Markets. Mitomics has positioned their company to be a leaders in the niche market of mitochondrial DNA (mtDNA) technology. They claim their unique structural and functional characteristic of mtDNA make it a highly sought after system… Read More

Twitter
Facebook
LinkedIn
Pinterest
Reddit
HackerNews
Telegram
Weibo
Email
Print
Subscribe

Read more in: Canada, Offerings | Tagged biotechnology, canada, mitomics technologies, molecular testing, optimize capital markets